A few months ago, we launched the Zero to One Program with a simple but ambitious goal: to find one visionary founder and become their technical co-founder, turning a bold idea into a real-world product with zero cost and zero equity. The response was overwhelming, filled with brilliant ideas and passionate entrepreneurs. After a rigorous selection process, we faced the difficult task of choosing just one.

Today, we couldn’t be more thrilled to announce that we’ve found our founder.

Meet the Visionary: Dr. Shivam Pandya

We are proud to announce that Dr. Shivam Pandya, a third-year surgical resident, is the selected founder for the inaugural Converge Labs Zero to One Program.

Shivam brings a rare and powerful combination of deep domain expertise and a sharp entrepreneurial mindset. He lives and breathes the clinical realities of the healthcare system. He has been in the trenches, witnessing firsthand the critical inefficiencies that impact both hospital operations and patient lives. This experience, combined with a background in a business-oriented family and a VC fellowship, gives him a unique vantage point to not only identify a problem but also envision a viable, scalable solution.

The Mission

Shivam's mission is to tackle a high-stakes challenge in emergency medicine: trauma triage.

When a patient arrives at a hospital after a severe injury, a crucial decision is made: are they a "Level 1" trauma (critically ill, needing immediate surgery) or a "Level 2" (more stable)? This decision dictates the scale of the hospital's response, mobilizing entire surgical teams and resources in minutes.

The Problem: Today, this critical decision is often made by a triage nurse based on limited data and subjective factors. This leads to a massive rate of "over-triage," where Level 2 traumas are mistakenly escalated to Level 1. National guidelines accept an over-triage rate of up to 50%, but Shivam notes that many community hospitals see rates as high as 70%. This wastes millions in resources, pulls surgeons away from other duties, and drains operational efficiency. On the flip side, "under-triage" is even more dangerous, delaying critical care and worsening patient outcomes.

The Solution: Shivam's company, Triagents AI, will use a machine learning algorithm to bring data-driven precision to this process. By analyzing objective data points, like vitals, Glasgow Coma Scale (GCS) scores, and mechanism of injury, the software will provide an instant, accurate recommendation for trauma activation. The goal is to reduce costly over-triage and, more importantly, prevent life-threatening under-triage.

As Shivam explained, "Not a single company has targeted trauma care [with AI]... I think that this is a big field in which we can see the operational workflow of the hospital drastically increase if this is targeted appropriately."

Why We Chose Shivam

Shivam’s proposal stood out because it represents the very essence of the Zero to One Program: a bold idea with a clear business case, led by a founder with an undeniable right to solve the problem. His vision to apply cutting-edge AI to a field that has remained unchanged for years is exactly the kind of high-impact innovation we set out to support.

He isn’t just an outsider with an idea; he is a practitioner poised to build the exact tool he and his colleagues desperately need. This is what makes a founder unstoppable.

We are incredibly excited to partner with Shivam Pandya to build Triagents AI from the ground up. Over the next three months, we will be working side-by-side to develop, refine, and launch a product with the potential to redefine emergency response.

Thank you to everyone who applied to the program. Please follow our journey as we turn this incredible vision into reality. The future of trauma care is about to get a whole lot smarter. 🧠